Genentech

Roche looking to sell or shut down California biologic drug plant
Roche looking to sell or shut down California biologic drug plant
Reuters
Roche
Genentech
California
drug manufacturing
Flag link:
BioNTech, Roche's experimental pancreatic cancer treatment wins Nature plaudit
BioNTech, Roche's experimental pancreatic cancer treatment wins Nature plaudit
Yahoo/Reuters
BioNTech
Roche
Genentech
pancreatic cancer
MRNA
Nature
vaccines
Flag link:
FDA Accepts Application for Genentech’s Vabysmo for the Treatment of Retinal Vein Occlusion (RVO)
FDA Accepts Application for Genentech’s Vabysmo for the Treatment of Retinal Vein Occlusion (RVO)
BioSpace
Roche
Genentech
FDA
Vabysmo
macular edema
retinal vein occlusion
Flag link:
Drugmakers take sides in Amgen, Regeneron fight over antibody patents
Drugmakers take sides in Amgen, Regeneron fight over antibody patents
BioPharma Dive
Amgen
Regeneron Pharmaceuticals
Sanofi
Supreme Court
patents
Pfizer
Bayer
Roche
Genentech
AstraZeneca
JNJ
Flag link:
Genentech opens up eye patients’ world with Vabysmo
Genentech opens up eye patients’ world with Vabysmo
Medical Marketing and Media
Genentech
Vabysmo
wet age-related macular degeneration
DTC ads
Flag link:
FDA Green Lights Roche's Polivy in First-Line DLBCL
FDA Green Lights Roche's Polivy in First-Line DLBCL
BioSpace
Roche
Genentech
Polivy
diffuse large B-cell lymphoma
FDA
Flag link:
Genentech reveals positive results from cancer combo therapy trial
Genentech reveals positive results from cancer combo therapy trial
Clinical Trials Arena
Genentech
Tecentriq
Avastin
liver cancer
hepatocellular carcinoma
Flag link:
Top biotech licensing deals of Q1 2023
Top biotech licensing deals of Q1 2023
BioSpace
biotech
licensing
Moderna Therapeutics
CytomX
Voyager Therapeutics
Neurocrine Biosciences
Kronos Bio
Genentech
Karuna Therapeutics
Goldfinch Bio
Flag link:
Genentech turns out lights at first commercial biologics plant, laying off 265 staffers
Genentech turns out lights at first commercial biologics plant, laying off 265 staffers
Fierce Pharma
Genentech
Roche
biologics
San Francisco
California
layoffs
Flag link:
At EpiBiologics, a pair of Genentech alumni wants to make next-gen protein degraders
At EpiBiologics, a pair of Genentech alumni wants to make next-gen protein degraders
BioPharma Dive
Genentech
EpiBiologics
protein degradation
Flag link:
FDA advisers question efficacy of Roche’s Polivy in first line LBCL
FDA advisers question efficacy of Roche’s Polivy in first line LBCL
BioSpace
Roche
Genentech
Polivy
LBCL
large B-cell lymphoma
Flag link:
Roche sues Biogen over royalties related to multiple sclerosis drug Tysabri
Roche sues Biogen over royalties related to multiple sclerosis drug Tysabri
Fierce Pharma
Roche
Genentech
patents
MS
multiple sclerosis
legal
Tysabri
Flag link:
Genentech's California biologics facility will support launches in cancer, neuroscience and more: exec
Genentech's California biologics facility will support launches in cancer, neuroscience and more: exec
Fierce Pharma
Genentech
California
Roche
biologics
drug manufacturing
Flag link:
Genentech to start construction on a new manufacturing facility in California
Genentech to start construction on a new manufacturing facility in California
Endpoints
Genentech
Roche
drug manufacturing
California
Flag link:
Roche offers up to $554M in biobucks to in-need Kronos for small-molecule discovery pact
Roche offers up to $554M in biobucks to in-need Kronos for small-molecule discovery pact
Fierce Biotech
Kronos Bio
biobucks
AML
Roche
Genentech
small molecule drugs
drug discovery
Flag link:
Roche further taps drug discovery spinout's Nimble tech in $1.1B biobucks deal
Roche further taps drug discovery spinout's Nimble tech in $1.1B biobucks deal
Fierce Biotech
Roche
Genentech
Nimble Therapeutics
biobucks
drug discovery
Flag link:
Genentech makes a flurry of marketing leadership hires
Genentech makes a flurry of marketing leadership hires
Medical Marketing and Media
Genentech
marketing
digital marketing
Flag link:
Roche Withdraws Tecentric for Bladder Cancer Indication
Roche Withdraws Tecentric for Bladder Cancer Indication
BioSpace
Roche
Genentech
bladder cancer
metastatic bladder cancer
Tecentriq
Flag link:
Genentech starts phase 2 trial to optimize delivery of eye disease cell therapy
Genentech starts phase 2 trial to optimize delivery of eye disease cell therapy
Fierce Pharma
Genentech
geographic atrophy
clinical trials
OpRegen
cell therapy
Flag link:
Best Places to Work in Biopharma 2023 Report Reveals Most Sought-After Employers
Best Places to Work in Biopharma 2023 Report Reveals Most Sought-After Employers
BioSpace
biotech
biopharma
employers
corporate culture
Moderna Therapeutics
Genentech
Pfizer
Amgen
AbbVie
Flag link:

Pages